Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALLO

Allogene Therapeutics Inc

May 29 • 04:00PM ET

2.17

-0.08 -3.56 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: SANA KRYS BMRN RYTM KYMR INCY NUVL VKTX AXSM NBIX

| Held by: VTI XBI IWM VXF IBB IWN FESM SCHA DFAS VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.77	Insider Own	25.94%	Shs Outstand	345.15M	Perf Week	10.71%
Market Cap	748.99M	Forward P/E	-	EPS next Y	-0.80	Insider Trans	-0.32%	Shs Float	255.61M	Perf Month	2.84%
Enterprise Value	563.15M	PEG	-	EPS next Q	-0.18	Inst Own	39.27%	Short Float	16.54%	Perf Quarter	-21.94%
Income	-173.76M	P/S	-	EPS this Y	17.63%	Inst Trans	7.32%	Short Ratio	4.44	Perf Half Y	59.56%
Sales	0.00M	P/B	1.90	EPS next Y	-11.10%	ROA	-38.45%	Short Interest	42.28M	Perf YTD	58.39%
Book/sh	1.14	P/C	2.81	EPS next 5Y	6.46%	ROE	-52.32%	52W High	4.46 -51.35%	Perf Year	83.90%
Cash/sh	0.77	P/FCF	-	EPS past 3/5Y	28.61% 16.08%	ROIC	-49.43%	52W Low	0.98 120.48%	Perf 3Y	-60.76%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.98% 6.45%	Perf 5Y	-91.56%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	37.45%	Oper. Margin	-	ATR (14)	0.17	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.65	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	49.54	Recom	1.36
Dividend Gr. 3/5Y	- -	Current Ratio	9.65	EPS Q/Q	36.09%	SMA20	1.00%	Beta	0.47	Target Price	8.35
Payout	-	Debt/Eq	0.29	Sales Q/Q	-	SMA50	-5.57%	Rel Volume	1.08	Prev Close	2.25
Employees	152	LT Debt/Eq	0.26	Earnings	May 13 AMC	SMA200	27.63%	Avg Volume	9.52M	Price	2.17
IPO	Oct 11, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.31% -100.00%	Trades		Volume	10,281,413	Change	-3.56%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)